Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
05.11.24
/
50%
€459.85
Target price
05.11.25
€536.01
Performance (%)
-21.69%
End price
06.11.25
€360.10
Summary
This prediction ended on 06.11.25 with a price of €360.10. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.69%. UBS_Group_AG has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% | -13.165% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by UBS_Group_AG for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $562.00 to $586.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
11.86%
12.12.25
12.12.25
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.15
09.12.25
09.12.25
-
09.12.26
09.12.26
1.60%
12.12.25
12.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.60
07.11.25
07.11.25
€473.22
07.11.26
07.11.26
9.25%
12.12.25
12.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-21.84%
18.10.25
18.10.25